KOMITA HIDEO 込田英夫

Researcher Number	90534561
Affiliation (based on the past Project Information) *help	2016 – 2018: 東京慈恵会医科大学, 医学部, 助教 2014 – 2015: 東京慈恵会医科大学, 医学部, 講師 2010 – 2013: 東京慈恵会医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Gastroenterology / Tumor immunology Except Principal Investigator Infectious disease medicine
Keywords	Principal Investigator GIST / WT1 / NK細胞 / Galectin-9 / Tim-3 / Hemoglobin-beta1 / 細胞障害性T細胞 / PD-1 / PD-L1 / 免疫チェックポイント … More / 抗腫瘍免疫 / 腫瘍浸潤単核球 / 初代培養 / 免疫チェックポイント阻害剤 / CD8+T cell / NK cell / Imatinib / epitope spreading / Sunitinib malate / Tolerance / EphA2 / pericyte / 免疫チェックポイント機構 / immunetherapy / 免疫チェックポイント分子 / ヘモグビンβ / がんワクチン / ヘモグロビンベータ / スニチニブ / 免疫療法 / 癌ワクチン / Sutent / 周細胞 … More Except Principal Investigator メタゲノム解析 / T-RFLP法 / 細菌DNA / 粘膜細菌フローラ / 潰瘍性大腸炎 Less

anti tumor immunology against GIST through immunecheckpoint mechnismPrincipal Investigator
- Principal Investigator
  
  KOMITA HIDEO
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Jikei University School of Medicine
Cancer vaccines targeting tumor blood vessels in GISTPrincipal Investigator
- Principal Investigator
  
  KOMITA HIDEO
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Jikei University School of Medicine
Hemoglobin-beta1 as cancer antigen against GISTPrincipal Investigator
- Principal Investigator
  
  KOMITA Hideo
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor immunology
- Research Institution
  Jikei University School of Medicine
Mucosa-associated bacteria in ulcerative colitis before and after new antibiotic combination therapy : DNA polymorphism analysis
- Principal Investigator
  
  OHKUSA Toshifumi
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Infectious disease medicine
- Research Institution
  Jikei University School of Medicine

All 2016 2015 2014 2013 2012 2011 2010 Other

All Journal Article Presentation Other

[Journal Article] PhaseI/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells inpatients with glioblastoma.2016
- Author(s)
  Akasaki Y, Kikuchi T, Homma S, Koido S, Ohkusa T, Tasaki T, Hayashi K, Komita H, Watanabe N, Suzuki Y, Yamamoto Y, Mori R, Arai T, Tanaka T, Joki T, Yanagisawa T, Murayama Y.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 65 Pages: 1499-1509
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09292
[Journal Article] Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression on human gastrointestinal stromal tumors.2015
- Author(s)
  Komita H, Koido S, Hayashi K, Kan S, Ito M, Kamata Y, Suzuki M, Homma S
- Journal Title
  
  Oncology Rep.
  
  Volume: 34 Issue: 4 Pages: 2099-105
- DOI
  10.3892/or.2015.4149
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460936
[Journal Article] Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the anti tumor effects of traszumab emtasine.2015
- Author(s)
  Kan S, Koido S, Okamoto M, Hayashi K, Ito M, Kamata Y, Komita H, Nagasaki E, Homma S.
- Journal Title
  
  Oncol Rep.
  
  Volume: 34 Issue: 1 Pages: 504-10
- DOI
  10.3892/or.2015.3974
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25460936, KAKENHI-PROJECT-25463119
[Journal Article] Up-regulation of HER2 by gemcitabine enhances the anti tumor effect of combined gemcitabine and trastumabemtasine treatment on pancreatic ductal adenocarcinoma cells.2015
- Author(s)
  Kan S, Koido S, Okamoto M, Hayashi K, Ito M, Kamata Y, Komita H, Nagasaki E, Homma S.
- Journal Title
  
  BMC Cancer.
  
  Volume: 15 Issue: 1 Pages: 726-726
- DOI
  10.1186/s12885-015-1772-1
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25460936, KAKENHI-PROJECT-25463119
[Journal Article] Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells.2014
- Author(s)
  1.Koido S, Ito M, Sagawa Y, Okamoto M, Hayashi K, Nagasaki E, Kan S, Komita H, Kamata Y, Homma S.
- Journal Title
  
  Cancer Immunology Immunotherapy
  
  Volume: 63 Issue: 5 Pages: 459-468
- DOI
  10.1007/s00262-014-1531-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24501334, KAKENHI-PROJECT-25460936, KAKENHI-PROJECT-25463119
[Journal Article] Production of corticotropin-released factor and urocortin from human monocyte-derived dendritic cells is stimulated by commensal bacteria in intestine.2014
- Author(s)
  Koido S, Ohkusa T, Kan S, Takakura K, Saito K, Komita H, Ito Z, Kobayashi H, Takami S, Uchiyama K, Arakawa H, Ito M, Okamoto M, Kajihara M, Homma S, Tajiri H.
- Journal Title
  
  World J Gastroenterol.
  
  Volume: 20 Issue: 39 Pages: 14420-9
- DOI
  10.3748/wjg.v20.i39.14420
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460936, KAKENHI-PROJECT-25463119
[Journal Article] Wilm's tumor gene(WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer.2014
- Author(s)
  Nishida S, Koido S, Takeda Y, Homma S, Komita H, Takahara A, Morita S, Ito T, Morimoto S, Hara K, Tsuboi A, Oka Y, Yanagisawa S, Toyama Y, Ikegami T, Kitagawa T, Eguchi H, Wada H, Nagano H, Nakata J, Nakae Y, Hosen N, Oji Y, Tanaka T, Kawase I, Kumanogoh A, Sakamoto J, Doki Y, MoriM, Ohkusa T, Tajiri H, Sugiyama H.
- Journal Title
  
  J Immunoher.
  
  Volume: 37 Pages: 105-14
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25460936
[Journal Article] Fusions between dendritic cells and whole tumor cells as anticancer vaccines.2013
- Author(s)
  Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Uchiyama K, Kajihara M, Arihiro S, Imazu H, Arakawa H, Kan S, Komita H, Ito M, Ohkusa T, Gong J, Tajiri H.
- Journal Title
  
  Oncoimmunology
  
  Volume: 2(5)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460936
[Journal Article] Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions.2013
- Author(s)
  Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Uchiyama K, Kajihara M, Arihiro S, Imazu H, Arakawa H, Kan S, Komita H,Kamata Y, Ito M, Ohkusa T, Gong J, Tajiri H.
- Journal Title
  
  Oncoimmunology
  
  Volume: 2(9)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460936
[Journal Article] Combined TLR2/4-activated dendritic/tumor cell fusions induce augmented cytotoxic T lymphocytes.2013
- Author(s)
  Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Takahara A, Odahara S, Tsukinaga S, Yukawa T, Mitobe J, Matsudaira H, Nagatsuma K, Uchiyama K, Kajihara M, Arihiro S, Imazu H, Arakawa H, Kan S, Komita H, Ito M, Ohkusa T, Gong J, Tajiri H.
- Journal Title
  
  PloS One.
  
  Volume: 8(3)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460936
[Journal Article] Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice.2012
- Author(s)
  Zhao X, Bose A, Komita H, Taylor JL, Chi N, Lowe DB, Okada H, Cao Y, Mukhopahyay D, Cohen PA, Storkus WJ.
- Journal Title
  
  J Immunol.
  
  Volume: 188(4) Issue: 4 Pages: 1782-1788
- DOI
  10.4049/jimmunol.1101644
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Gemcitabine enhances Wilms' tumor gene Immunotherapy synergizes with chemotherapy targeting pancreatic cancer2012
- Author(s)
  Koido S., Homma S., Ito M., et al.
- Journal Title
  
  Immunotherpy
  
  Volume: 4 Issue: 1 Pages: 5-7
- DOI
  10.2217/imt.11.150
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22650231, KAKENHI-PROJECT-22650232, KAKENHI-PROJECT-22700898, KAKENHI-PROJECT-23501289
[Journal Article] Current immunotherapeutic approaches in pancreatic cancer2011
- Author(s)
  Koido S., Homma S., Ito M., et al.
- Journal Title
  
  Clin Dev Immunol
  
  Volume: 267539 Pages: 1-15
- DOI
  10.1155/2011/267539
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22650231, KAKENHI-PROJECT-22650232, KAKENHI-PROJECT-22700898, KAKENHI-PROJECT-23501289
[Journal Article] Intratumoral Il-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor associated stromal antigens.2011
- Author(s)
  Zhao X, Bose A, Komita H, Taylor JL, Kawabe M, Chi N, Spokas L, Lowe DB, Goldbach C, Alber S, Watkins SC, Butterfield LH, Kalinski P, Kirkwood JM, Storkus WJ
- Journal Title
  
  Mol Ther
  
  Volume: 19(4) Pages: 805-814
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.2011
- Author(s)
  Koido S, Homma S, Takahara A, Namiki Y, Komita H, Nagasaki E, Ito M, Nagatsuma K, Uchiyama K, Satoh K, Ohkusa T, Gong J, Tajiri H.
- Journal Title
  
  J Biomed Biotechnol
  
  Volume: 2011 Pages: 910836-910836
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines2011
- Author(s)
  Koido S, Homma S, Takahara A, Namiki Y, Komita H, et al
- Journal Title
  
  J Biomed Biotechnol
  
  Volume: 910836 Pages: 1-13
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Gemcitabine enhances Wilm's tumor gene WT1 expression and sensitizes human pancreatic cance cells with WT1-specific T-cell-mediated antitumor immnue response2011
- Author(s)
  Takahara A, Koido S, Ito M, Nagasaki E, Sagawa Y, Iwamoto T, Komita H, et al
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 69(9) Pages: 1289-1297
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] [膵癌診療と研究の最先端] 進行膵癌に対するgemcitanbine併用WT1標的免疫療法の意義(解説/特集)2011
- Author(s)
  小井戸薫雄、本間定、高原映崇、込田英夫、大草敏史、田尻久雄
- Journal Title
  
  胆と膵
  
  Volume: 32(9) Pages: 887-891
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune reponse2011
- Author(s)
  Takahara A, Koido S, Ito M, Nagasaki E, Sagawa Y, Iwamoto T, Komita H, Ochi T, Fujiwara H, Yasukawa M, Mineno J, Shiku H, Nishida S, Sugiyama H, Tajiri H, Homma S.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 60(9) Pages: 1289-1297
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Intratumoral IL-12 gene therapy results in the crosspriming of Tcl cells reactive against tumor-associated stromal antigens2011
- Author(s)
  Zhao X, Bose A, Komita H, et al
- Journal Title
  
  Mol Ther
  
  Volume: 19(4) Pages: 805-814
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy-versus patient-derived fusions2010
- Author(s)
  Koido S, Hara E, Homma S, Namiki Y, Komita H,Takahara A, Nagasaki E, Ito M, Sagawa Y, Mitsunaga M, Uchiyama K, Satoh K, Arihiro S, Ohkusa T, Gong J, Tajiri H.
- Journal Title
  
  Clin Immunol
  
  Volume: 135(3) Pages: 384-400
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Dendritic/pancreatic carcinoma fusions for clinical use ; Comparative functional nalysis of healthy-versus patient-derived fusions.2010
- Author(s)
  Koido S, Hara E, Homma S, Namiki Y, Komita H, et al.
- Journal Title
  
  Clin.Immunol.
  
  Volume: 135(3) Pages: 384-400
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Regulation of tumor immunity by tumor/dendritic cell fusions.2010
- Author(s)
  Koido S, Homma S, Hara E, Namiki Y, Takahara A, Komita H,Nagasaki E, Ito M, Ohkusa T, Gong J, Tajiri H
- Journal Title
  
  Journal of Immunology Research
  
  Volume: 201 Issue: 1 Pages: 516768-516768
- DOI
  10.1155/2010/516768
- ISSN
  2314-8861, 2314-7156
- Data Source
  KAKENHI-PROJECT-22700898
[Journal Article] Regulation of tumor immunity by tumor/dendritic cell fusions.2010
- Author(s)
  Koido S, Hara E, Homma S, Namiki Y, Takahara A, Komita H, et al.
- Journal Title
  
  Clin.Dev.Immunol.
  
  Pages: 516768-516768
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700898
[Presentation] Tim-3/galectin-9interaction might be associated with the immunosuppression of Gastrointestinal stromal tumor(GIST)2015
- Author(s)
  Hideo Komita, Shigeo Koido, Hisao Tajiri, Masafumi Suzuki, Sadamu Homma
- Organizer
  2015 AACR annual meeting
- Place of Presentation
  Pennsylvania Convention Center
- Year and Date
  2015-04-20
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25460936
[Presentation] 進行膵癌患者血中の可溶性PDL-12015
- Author(s)
  本間定、小井戸薫雄、佐川由紀子、林和美、込田英夫、鎌田裕子、伊藤正紀
- Organizer
  第７４回日本癌学会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2015-10-09
- Data Source
  KAKENHI-PROJECT-25460936
[Presentation] GISTにおける免疫チェックポイント関連分子Tim-3/galectin-9の発現2015
- Author(s)
  込田英夫、小井戸薫雄、林和美、伊藤正紀、鎌田裕子、田尻久雄、鈴木正章、本間定
- Organizer
  第７４回日本癌学会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-25460936
[Presentation] セリンプロテアーゼ阻害剤はがん細胞のIFN-γ誘導性PD-L1の発現上昇を抑制する2015
- Author(s)
  佐川由紀子、林和美、小井戸薫雄、カンシン、込田英夫、鎌田裕子、伊藤正紀、本間定
- Organizer
  第７４回日本癌学会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2015-10-09
- Data Source
  KAKENHI-PROJECT-25460936
[Presentation] 難治性消化管間葉系腫瘍(GIST)に対する癌免疫療法の検討2014
- Author(s)
  込田　英夫、小井戸薫雄、カン　シン、小林由紀子、林和美、鎌田裕子、伊藤正紀、鈴木正章、田尻久雄、本間定
- Organizer
  第２７回日本バイオセラピー学会学術集会
- Place of Presentation
  大阪
- Year and Date
  2014-12-04
- Data Source
  KAKENHI-PROJECT-25460936
[Presentation] Gastrointestinal stromal tumors might be immunogenic to become a new target of cancer immunotherapy.2014
- Author(s)
  Hideo Komita, Shigeo Koido, Shin Kan, Masaki Ito, Yuko Kamata, Yukiko Kobayashi, Kouji Nakata, Norio Mitsumori, Naoto Takahashi, Kazuto Tuboi, Masafumi Suzuki, Hisao Tajiri, Sadamu Homma.
- Organizer
  第７３回日本癌学会
- Place of Presentation
  横浜
- Year and Date
  2014-09-25
- Data Source
  KAKENHI-PROJECT-25460936
[Presentation] 消化器癌の免疫学的解析と治療腫瘍血管ペリサイトを標的とした新たながん免疫療法と GIST 治療への応用2012
- Author(s)
  込田英夫、小井戸薫雄、本間定
- Organizer
  日本消化器病学会雑誌109 巻臨時増総会pageA175
- Data Source
  KAKENHI-PROJECT-22700898
[Presentation] iPS 細胞から腫瘍血管を標的とした癌ワクチンの開発(Generation of a cancer vaccine targeting tumor vessel from iPS cells)2011
- Author(s)
  本間定、佐川由紀子、伊藤正紀、永崎栄次郎、高原映崇、込田英夫、小井戸薫雄
- Organizer
  日本癌学会総会記事 70回 Page82
- Data Source
  KAKENHI-PROJECT-22700898
[Presentation] 膵癌に対するゲムシタビン併用 WT1 ペプチドワクチン療法の臨床効果と免疫誘導(Memory WT1-CTLs is a useful marker to predict the clinical outcome: WT1 vaccine in the combination with gemcitabine)2011
- Author(s)
  西田純幸、小井戸薫雄、原一馬、森本創世子、坪井昭博、本間定、武田裕、込田英夫、永野裕昭、岡芳弘、大草敏史、田尻久雄、杉山治夫
- Organizer
  日本癌学会総会記事 70回page395
- Data Source
  KAKENHI-PROJECT-22700898
[Presentation] iPS 細胞から腫瘍血管を標的とした癌ワクチン療法の作製2011
- Author(s)
  本間定、佐川由紀子、伊藤正紀、永崎栄次郎、高原映崇、込田英夫、小井戸薫雄
- Organizer
  日本がん免疫学会総会プログラム 15回 Page105
- Data Source
  KAKENHI-PROJECT-22700898
[Presentation] 、WT1 ペプチドがん免疫療法の現状と将来膵がんに対する WT1 ペプチド免疫療法2010
- Author(s)
  本間定、小井戸薫定、込田英夫、高原映崇、大草敏史、西田純幸、武田裕、岡芳弘、伊藤濤記、坪井昭博、杉山治夫
- Organizer
  日本癌治療学会誌 45 巻 2 号 Page450
- Data Source
  KAKENHI-PROJECT-22700898
[Presentation] 潰瘍性大腸炎に対する新規抗菌薬多剤併用AFM療法2010
- Author(s)
  月永真太郎、大草敏史、及川紘太郎、湯川豊一、小田原俊一、永妻啓介、込田英夫、内山幹、佐藤憲一、天野克之、古谷徹、小井戸薫雄、田尻久雄
- Organizer
  第96回日本消化器病学会総会
- Place of Presentation
  新潟
- Data Source
  KAKENHI-PROJECT-20591209
[Presentation] 腫瘍血管ペリサイトを標的とした新たながん免疫療法とGIST治療への応用
- Author(s)
  込田英夫、小井戸薫雄、本間定
- Organizer
  第98回日本消化器病学会総会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-22700898
[Presentation] 消化管間葉系腫瘍に対するWT1発現の検討
- Author(s)
  込田英夫、小井戸薫雄、鈴木正章、田尻久雄、本間定
- Organizer
  WT1研究会
- Place of Presentation
  大阪大学
- Data Source
  KAKENHI-PROJECT-25460936
[Presentation] 腹部超音波検査で肝血管腫所見を経過観察中肝細胞癌と診断、切除に至った一例
- Author(s)
  込田英夫、伊藤恭子、國安祐二、久保恭仁、小田彩、中崎薫、真島香代子、常喜眞理、銭谷幹夫、和田高士
- Organizer
  人間ドック学会
- Place of Presentation
  静岡県浜松
- Data Source
  KAKENHI-PROJECT-25460936
[Presentation] 進行膵癌に対するWT1ペプチドワクチンとゲムシタビンによる集学的治療法の選択基準
- Author(s)
  小井戸薫雄、西田純幸、本間定、込田英夫、高原映崇、高倉一樹、内山幹、今津博雄、荒川廣志、大草敏史、田尻久雄
- Organizer
  JDDW 2013 Tokyo
- Place of Presentation
  東京　品川
- Data Source
  KAKENHI-PROJECT-25460936
[Presentation] 人間ドック受診者の非アルコール性脂肪肝における肝線維化指標FIB-4 indexの分布
- Author(s)
  和田高士、銭谷幹男、國安祐二、伊藤恭子、込田英夫、久保恭仁、真島香代子、前田俊彦、常喜眞理
- Organizer
  人間ドック学会
- Place of Presentation
  静岡県浜松
- Data Source
  KAKENHI-PROJECT-25460936
[]
[]

1. OHKUSA Toshifumi (50160445)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
2. KOIDO Shigeo (70266617)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
3. ODAHARA Shunichi (50445673)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. 本間定 (50192323)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
5. 伊藤正紀

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

KOMITA HIDEO 込田 英夫

Research Projects

Research Products

Co-Researchers

anti tumor immunology against GIST through immunecheckpoint mechnismPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Cancer vaccines targeting tumor blood vessels in GISTPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Hemoglobin-beta1 as cancer antigen against GISTPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Mucosa-associated bacteria in ulcerative colitis before and after new antibiotic combination therapy : DNA polymorphism analysis

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] PhaseI/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells inpatients with glioblastoma.2016

Author(s)

Journal Title

Data Source

[Journal Article] Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression on human gastrointestinal stromal tumors.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the anti tumor effects of traszumab emtasine.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Up-regulation of HER2 by gemcitabine enhances the anti tumor effect of combined gemcitabine and trastumabemtasine treatment on pancreatic ductal adenocarcinoma cells.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Production of corticotropin-released factor and urocortin from human monocyte-derived dendritic cells is stimulated by commensal bacteria in intestine.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Wilm's tumor gene(WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer.2014

Author(s)

Journal Title

Data Source

[Journal Article] Fusions between dendritic cells and whole tumor cells as anticancer vaccines.2013

Author(s)

Journal Title

Data Source

[Journal Article] Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions.2013

Author(s)

Journal Title

Data Source

[Journal Article] Combined TLR2/4-activated dendritic/tumor cell fusions induce augmented cytotoxic T lymphocytes.2013

Author(s)

Journal Title

Data Source

[Journal Article] Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice.2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Gemcitabine enhances Wilms' tumor gene Immunotherapy synergizes with chemotherapy targeting pancreatic cancer2012

Author(s)

KOMITA HIDEO 込田英夫